These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 11918852

  • 1. Effects of reactive oxygen species on lymphokine-activated killer cells in patients with bladder cancer.
    Wang ZP, Chen YR, Zheng RL, Lu JZ, Wang JJ.
    Acta Pharmacol Sin; 2002 Mar; 23(3):257-62. PubMed ID: 11918852
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. LAK-cell-mediated cytotoxicity against tumor cell targets used to monitor the stimulatory effect of interleukin-2: cytotoxicity, target recognition and phenotype of effector cells lysing the Daudi, T24 and K562 tumor cell lines.
    Hermann GG, Zeuthen J, Claësson MH.
    Nat Immun; 1992 Mar; 11(1):7-16. PubMed ID: 1611282
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhancement of murine lymphokine-activated killer cell activity by retinoic acid.
    Lin TH, Chu TM.
    Cancer Res; 1990 May 15; 50(10):3013-8. PubMed ID: 1970751
    [Abstract] [Full Text] [Related]

  • 10. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    Kasid A, Bell GI, Director EP.
    J Immunol; 1988 Jul 15; 141(2):690-8. PubMed ID: 3133414
    [Abstract] [Full Text] [Related]

  • 11. Effects of N(G)-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on IL-2-induced LAK cell generation in vivo and in vitro in healthy and tumor-bearing mice.
    Orucevic A, Lala PK.
    Cell Immunol; 1996 Apr 10; 169(1):125-32. PubMed ID: 8612285
    [Abstract] [Full Text] [Related]

  • 12. The role of lymphotoxin in the IL-2-driven differentiation of human lymphokine-activated T-killer (T-LAK) cells in vitro.
    Abe Y, Van Eden M, Gatanaga M, Wang FI, Brightbill HD, Granger GA, Gatanaga T.
    Lymphokine Cytokine Res; 1993 Oct 10; 12(5):279-83. PubMed ID: 8260536
    [Abstract] [Full Text] [Related]

  • 13. [The effect of MPS on LAK cell growth and its cytotoxic activity against laryngeal cancer (HEP-2)].
    Wang J, Zhu X, Chen J.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996 Oct 10; 31(5):283-6. PubMed ID: 9642362
    [Abstract] [Full Text] [Related]

  • 14. Generation of lymphokine-activated killer activity in rodents but not in humans is nitric oxide dependent.
    Juretic A, Spagnoli GC, von Bremen K, Hörig H, Filgueira L, Lüscher U, Babst R, Harder F, Heberer M.
    Cell Immunol; 1994 Sep 10; 157(2):462-77. PubMed ID: 8069927
    [Abstract] [Full Text] [Related]

  • 15. Sequential TNF and TGF-beta regulation of expansion and induction of cytotoxicity in long-term cultures of lymphokine-activated killer cells.
    Koberda J, Przepiorka D, Moser RP, Grimm EE.
    Lymphokine Cytokine Res; 1994 Apr 10; 13(2):139-45. PubMed ID: 8061115
    [Abstract] [Full Text] [Related]

  • 16. LAK cell mediated apoptosis of human bladder cancer cells involves a pH-dependent endonuclease system in the cancer cell: possible mechanism of BCG therapy.
    Shemtov MM, Cheng DL, Kong L, Shu WP, Sassaroli M, Droller MJ, Liu BC.
    J Urol; 1995 Jul 10; 154(1):269-74. PubMed ID: 7776443
    [Abstract] [Full Text] [Related]

  • 17. Generation of human lymphokine-activated killer cells following an IL-2 pulse in elderly cancer patients.
    Provinciali M, Di Stefano G, Stronati S, Fabris N.
    Cytokine; 1998 Feb 10; 10(2):132-9. PubMed ID: 9512903
    [Abstract] [Full Text] [Related]

  • 18. Ability of lymphokine-activated killer cells to lyse mycobacteria-infected cells.
    Chiplunkar SV, Deshmukh MA, Kode JA, Gangal SG, Deo MG.
    Acta Leprol; 1997 Feb 10; 10(4):203-8. PubMed ID: 9447253
    [Abstract] [Full Text] [Related]

  • 19. Lymphokine-activated killer cells can kill target cells not only by early killing but also by late killing, and the late killing level against autotumor cell line.
    Komatsu F, Ishiguro K.
    Oncol Res; 2003 Feb 10; 13(4):235-41. PubMed ID: 12659424
    [Abstract] [Full Text] [Related]

  • 20. Fibrin coating of bladder tumor cells (T24) is not protective against LAK cell cytotoxicity.
    Carr ME, Sajer SA, Spaulding A.
    J Lab Clin Med; 1992 Feb 10; 119(2):132-8. PubMed ID: 1740625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.